Գինեկոմաստիա (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Գինեկոմաստիա" in Armenian language version.

refsWebsite

Global rank Armenian rank

42nih.gov

4^th place

3^rd place

32doi.org

2^nd place

4^th place

6web.archive.org

1^st place

5archive.org

6^th place

5worldcat.org

5^th place

10^th place

3books.google.com

3^rd place

17^th place

2eje-online.org

low place

1aappublications.org

3,763^rd place

1,255^th place

1touro.edu

low place

4,097^th place

1jnephrol.com

low place

1mayoclinic.com

3,634^th place

498^th place

1redjournal.org

low place

1unitedhealthcareonline.com

low place

1aetna.com

low place

1cigna.com

low place

1yimg.com

low place

aappublications.org

pediatrics.aappublications.org

Shulman, DI; Francis, GL; Palmert, MR; Eugster, EA; Lawson Wilkins Pediatric Endocrine Society Drug and Therapeutics Committee (April 2008). «Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development». Pediatrics. 121 (4): e975–983. doi:10.1542/peds.2007-2081. PMID 18381525.

aetna.com

«Clinical Policy Bulletin: Breast Reduction Surgery and Gynecomastia Surgery». Aetna Inc. 2012. Վերցված է 2013 թ․ փետրվարի 12-ին.are

archive.org

Johnson RE, Murad MH (November 2009). «Gynecomastia: pathophysiology, evaluation, and management». Mayo Clinic Proceedings. 84 (11): 1010–1015. doi:10.4065/84.11.1010. PMC 2770912. PMID 19880691.
Dickson, G (April 2012). «Gynecomastia». American Family Physician. 85 (7): 716–722. PMID 22534349.
Goldspiel BR, Kohler DR (1990). «Flutamide: An Antiandrogen for Advanced Prostate Cancer». Ann Pharmacother. 24 (6): 616–623. doi:10.1177/106002809002400612. PMID 2193461. «[...] They [in patients treated with flutamide] observed mild gynecomastia in 30 patients (57%), moderate gynecomastia in 19 (36%), and massive gynecomastia in four patients (8%). Complaints of nipple and areolar tenderness were noted in 50/53 patients (94%%)." Airhart et al. reported that 42% of patients receiving flutamide 750 mg/d or 1500 mg/d developed gynecomastia within 12 weeks of starting treatment with an apparent direct correlation between the dose of flutamide administered and the severity of gynecomastia. In another study, two of five evaluable patients developed moderate gynecomastia with mild tenderness at four and eight weeks after starting flutamide 750 mg/d. Patients with pre-existing gynecomastia as a result of previous endocrine therapy with estrogens sustained no worsening of their gynecomastia and may have improved symptomatically." Keating et al.»
Saylor, PJ; Smith, MR (May 2009). «Metabolic complications of androgen deprivation therapy for prostate cancer». The Journal of Urology. 181 (5): 1998–2006. doi:10.1016/j.juro.2009.01.047. PMC 2900631. PMID 19286225.
Koshy, JC; Goldberg, JS; Wolfswinkel, EM; Ge, Y; Heller, L (January 2011). «Breast cancer incidence in adolescent males undergoing subcutaneous mastectomy for gynecomastia: is pathologic examination justified? A retrospective and literature review». Plastic and Reconstructive Surgery. 127 (1): 1–7. doi:10.1097/PRS.0b013e3181f9581c. PMID 20871489.

books.google.com

Ghosh, Amit (2010). Mayo Clinic internal medicine board review (9th ed.). [Rochester, MN.]: Mayo Clinic Scientific Press. էջ 209. ISBN 978-0-19-975569-1.
Fleisher, Gary (2010). Textbook of pediatric emergency medicine (6th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health. էջ 731. ISBN 978-1-60547-159-4.
Melmed, Shlomo (2011). Williams Textbook of Endocrinology: Expert Consult. էջեր Chapter 19. ISBN 978-1-4377-3600-7.

cigna.com

«Cigna Medical Coverage Policy» (PDF). Surgical Treatment of Gynecomastia. Cigna. 2012. Արխիվացված է օրիգինալից (PDF) 2012 թ․ սեպտեմբերի 5-ին. Վերցված է 2013 թ․ փետրվարի 12-ին.

doi.org

Niewoehner, CB; Schorer, AE (March 2008). «Gynaecomastia and breast cancer in men». BMJ. 336 (7646): 709–713. doi:10.1136/bmj.39511.493391.BE. PMC 2276281. PMID 18369226.
Shulman, DI; Francis, GL; Palmert, MR; Eugster, EA; Lawson Wilkins Pediatric Endocrine Society Drug and Therapeutics Committee (April 2008). «Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development». Pediatrics. 121 (4): e975–983. doi:10.1542/peds.2007-2081. PMID 18381525.
Narula HS, Carlson HE (August 2014). «Gynaecomastia-pathophysiology, diagnosis and treatment». Nat Rev Endocrinol. 10 (11): 684–698. doi:10.1038/nrendo.2014.139. PMID 25112235.
Johnson RE, Murad MH (November 2009). «Gynecomastia: pathophysiology, evaluation, and management». Mayo Clinic Proceedings. 84 (11): 1010–1015. doi:10.4065/84.11.1010. PMC 2770912. PMID 19880691.
Wit JM, Hero M, Nunez SB (October 2011). «Aromatase inhibitors in pediatrics». Nature Reviews. Endocrinology. 8 (3): 135–47. doi:10.1038/nrendo.2011.161. PMID 22024975.
Deepinder F, Braunstein GD (2012). «Drug-induced gynecomastia: an evidence-based review». Expert Opinion on Drug Safety. 11 (5): 779–795. doi:10.1517/14740338.2012.712109. PMID 22862307.
Chau, A; Jafarian, N; Rosa, M (February 2016). «Male Breast: Clinical and Imaging Evaluations of Benign and Malignant Entities with Histologic Correlation». The American Journal of Medicine (Review). 129 (8): 776–91. doi:10.1016/j.amjmed.2016.01.009. PMID 26844632.
Devalia HL, Layer GT (April 2009). «Current concepts in gynaecomastia». Surgeon. 7 (2): 114–19. doi:10.1016/s1479-666x(09)80026-7. PMID 19408804.
Cordova A, Moschella F (2008). «Algorithm for clinical evaluation and surgical treatment of gynaecomastia». J Plast Reconstr Aesthet Surg. 61 (1): 41–9. doi:10.1016/j.bjps.2007.09.033. PMID 17983883.
Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B (2014 թ․ մարտի 19). «Gynecomastia: Clinical evaluation and management». Indian J Endocrinol Metab. 18 (2): 150–58. doi:10.4103/2230-8210.129104. PMC 3987263. PMID 24741509.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Deepinder, Fnu; Braunstein, Glenn D (2012). «Drug-induced gynecomastia: an evidence-based review». Expert Opinion on Drug Safety. 11 (5): 779–795. doi:10.1517/14740338.2012.712109. ISSN 1474-0338. PMID 22862307.
Barros, Alfredo Carlos Simões Dornellas de; Sampaio, Marcelo de Castro Moura (2012). «Gynecomastia: physiopathology, evaluation and treatment». São Paulo Medical Journal. 130 (3): 187–197. doi:10.1590/S1516-31802012000300009. ISSN 1516-3180. PMID 22790552. «Reinforcing the evidence suggesting that there is a relationship between chemicals and GM, it is worthwhile mentioning the epidemic onset observed among Haitian refugees in 1981 about four months after arrival in United States detention centers.22 After analyzing all identifiable environmental exposures, it was then found that phenothrin, a multi-insecticide contained in sprays that they had used was the causative agent.23 It is now widely known that phenothrin has antiandrogenic activity.»
Steven A. Brody MD; D. Lynn Loriaux MD (2003). «Epidemic Of Gynecomastia Among Haitian Refugees: Exposure To An Environmental Antiandrogen». Endocrine Practice. 9 (5): 370–375. doi:10.4158/EP.9.5.370. ISSN 1530-891X. PMID 14583418.
Grunseich, C; Fischbeck, KH (November 2015). «Spinal and Bulbar Muscular Atrophy». Neurologic Clinics. 33 (4): 847–54. doi:10.1016/j.ncl.2015.07.002. PMC 4628725. PMID 26515625.
Farida, Chentli; Faiza, Belhimer (2013). «Severe gynecomastia due to anti androgens intake: A case report and literature review». Indian Journal of Endocrinology and Metabolism. 17 (4): 730–2. doi:10.4103/2230-8210.113770. ISSN 2230-8210. PMC 3743379. PMID 23961495.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Gillatt, David (2006). «Antiandrogen treatments in locally advanced prostate cancer: are they all the same?». Journal of Cancer Research and Clinical Oncology. 132 (S1): 17–26. doi:10.1007/s00432-006-0133-5. ISSN 0171-5216. PMID 16845534. «Unlike CPA, nonsteroidal antiandrogens appear to be better tolerated than castration, allowing patients to maintain sexual activity, physical ability, and bone mineral density, but these agents have a higher incidence of gynecomastia and breast pain (mild to moderate in > 90% of cases).»
Goldspiel BR, Kohler DR (1990). «Flutamide: An Antiandrogen for Advanced Prostate Cancer». Ann Pharmacother. 24 (6): 616–623. doi:10.1177/106002809002400612. PMID 2193461. «[...] They [in patients treated with flutamide] observed mild gynecomastia in 30 patients (57%), moderate gynecomastia in 19 (36%), and massive gynecomastia in four patients (8%). Complaints of nipple and areolar tenderness were noted in 50/53 patients (94%%)." Airhart et al. reported that 42% of patients receiving flutamide 750 mg/d or 1500 mg/d developed gynecomastia within 12 weeks of starting treatment with an apparent direct correlation between the dose of flutamide administered and the severity of gynecomastia. In another study, two of five evaluable patients developed moderate gynecomastia with mild tenderness at four and eight weeks after starting flutamide 750 mg/d. Patients with pre-existing gynecomastia as a result of previous endocrine therapy with estrogens sustained no worsening of their gynecomastia and may have improved symptomatically." Keating et al.»
Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF (April 2014). «Aldosterone antagonists for preventing the progression of chronic kidney disease». Cochrane Database of Systematic Reviews. 4 (4): CD007004. doi:10.1002/14651858.CD007004.pub3. PMID 24782282.
Aiman, U; Haseen, MA; Rahman, SZ (December 2009). «Gynecomastia: An ADR due to drug interaction». Indian Journal of Pharmacology. 41 (6): 286–287. doi:10.4103/0253-7613.59929. PMC 2846505. PMID 20407562.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Nieschlag, E; Vorona, E (August 2015). «MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions». European Journal of Endocrinology. 173 (2): R47–58. doi:10.1530/EJE-15-0080. PMID 25805894. Արխիվացված է օրիգինալից 2015 թ․ դեկտեմբերի 15-ին. Վերցված է 2020 թ․ հունվարի 11-ին.
Barros AC, Sampaio Mde C (2012). «Gynecomastia: physiopathology, evaluation and treatment». São Paulo Medical Journal. 130 (3): 187–97. doi:10.1590/s1516-31802012000300009. PMID 22790552.
Diaz A, Luque L, Badar Z, Kornic S, Danon M (2016). «Prepubertal gynecomastia and chronic lavender exposure: report of three cases». J. Pediatr. Endocrinol. Metab. 29 (1): 103–107. doi:10.1515/jpem-2015-0248. PMID 26353172.
Iglesias, P; Carrero, JJ; Diez, JJ (January–February 2012). «Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options». Journal of Nephrology. 25 (1): 31–42. doi:10.5301/JN.2011.8481. PMID 21748720. Արխիվացված է օրիգինալից 2014 թ․ ապրիլի 19-ին. Վերցված է 2013 թ․ փետրվարի 9-ին.
Gourgari, E; Saloustros, E; Stratakis, CA (August 2012). «Large-cell calcifying Sertoli cell tumors of the testes in pediatrics». Current Opinion in Pediatrics. 24 (4): 518–522. doi:10.1097/MOP.0b013e328355a279. PMC 4132931. PMID 22732638.
Saylor, PJ; Smith, MR (May 2009). «Metabolic complications of androgen deprivation therapy for prostate cancer». The Journal of Urology. 181 (5): 1998–2006. doi:10.1016/j.juro.2009.01.047. PMC 2900631. PMID 19286225.
Gies I, Unuane D, Velkeniers B, De Schepper J (August 2014). «Management of Klinefelter syndrome during transition». European Journal of Endocrinology. 171 (2): R67–77. doi:10.1530/EJE-14-0213. PMID 24801585. Արխիվացված է օրիգինալից 2015 թ․ նոյեմբերի 16-ին.
Koshy, JC; Goldberg, JS; Wolfswinkel, EM; Ge, Y; Heller, L (January 2011). «Breast cancer incidence in adolescent males undergoing subcutaneous mastectomy for gynecomastia: is pathologic examination justified? A retrospective and literature review». Plastic and Reconstructive Surgery. 127 (1): 1–7. doi:10.1097/PRS.0b013e3181f9581c. PMID 20871489.
Wollina, U; Goldman, A (June 2011). «Minimally invasive esthetic procedures of the male breast». Journal of Cosmetic Dermatology. 10 (2): 150–155. doi:10.1111/j.1473-2165.2011.00548.x. PMID 21649820.
Agrawal, Sweety; Ganie, Mohd Ashraf; Nisar, Sobia (2017). Basics of Human Andrology. էջեր 451–458. doi:10.1007/978-981-10-3695-8_26. ISBN 978-981-10-3694-1.
Viani, GA; Bernardes da Silva, LG; Stefano, EJ (July 2012). «Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?». International Journal of Radiation Oncology, Biology, Physics. 83 (4): e519–e524. doi:10.1016/j.ijrobp.2012.01.036. PMID 22704706.
Wassersug, RJ; Oliffe, JL (April 2009). «The social context for psychological distress from iatrogenic gynecomastia with suggestions for its management». Journal of Sexual Medicine. 6 (4): 989–1000. doi:10.1111/j.1743-6109.2008.01053.x. PMID 19175864.
Wassersug, Richard J.; Oliffe, John L. (2009 թ․ ապրիլի 1). «The Social Context for Psychological Distress from Iatrogenic Gynecomastia with Suggestions for Its Management» (PDF). Journal of Sexual Medicine. 6 (4): 989–1000. doi:10.1111/j.1743-6109.2008.01053.x. PMID 19175864. Արխիվացված է օրիգինալից (PDF) 2018 թ․ սեպտեմբերի 9-ին. Վերցված է 2020 թ․ հունվարի 11-ին.

eje-online.org

Nieschlag, E; Vorona, E (August 2015). «MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions». European Journal of Endocrinology. 173 (2): R47–58. doi:10.1530/EJE-15-0080. PMID 25805894. Արխիվացված է օրիգինալից 2015 թ․ դեկտեմբերի 15-ին. Վերցված է 2020 թ․ հունվարի 11-ին.
Gies I, Unuane D, Velkeniers B, De Schepper J (August 2014). «Management of Klinefelter syndrome during transition». European Journal of Endocrinology. 171 (2): R67–77. doi:10.1530/EJE-14-0213. PMID 24801585. Արխիվացված է օրիգինալից 2015 թ․ նոյեմբերի 16-ին.

jnephrol.com

Iglesias, P; Carrero, JJ; Diez, JJ (January–February 2012). «Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options». Journal of Nephrology. 25 (1): 31–42. doi:10.5301/JN.2011.8481. PMID 21748720. Արխիվացված է օրիգինալից 2014 թ․ ապրիլի 19-ին. Վերցված է 2013 թ․ փետրվարի 9-ին.

mayoclinic.com

Mayo Clinic Staff (2010). «Tests and diagnosis». Mayo Clinic. Վերցված է 2013 թ․ փետրվարի 3-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Niewoehner, CB; Schorer, AE (March 2008). «Gynaecomastia and breast cancer in men». BMJ. 336 (7646): 709–713. doi:10.1136/bmj.39511.493391.BE. PMC 2276281. PMID 18369226.
Shulman, DI; Francis, GL; Palmert, MR; Eugster, EA; Lawson Wilkins Pediatric Endocrine Society Drug and Therapeutics Committee (April 2008). «Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development». Pediatrics. 121 (4): e975–983. doi:10.1542/peds.2007-2081. PMID 18381525.
Narula HS, Carlson HE (August 2014). «Gynaecomastia-pathophysiology, diagnosis and treatment». Nat Rev Endocrinol. 10 (11): 684–698. doi:10.1038/nrendo.2014.139. PMID 25112235.
Johnson RE, Murad MH (November 2009). «Gynecomastia: pathophysiology, evaluation, and management». Mayo Clinic Proceedings. 84 (11): 1010–1015. doi:10.4065/84.11.1010. PMC 2770912. PMID 19880691.
Wit JM, Hero M, Nunez SB (October 2011). «Aromatase inhibitors in pediatrics». Nature Reviews. Endocrinology. 8 (3): 135–47. doi:10.1038/nrendo.2011.161. PMID 22024975.
Deepinder F, Braunstein GD (2012). «Drug-induced gynecomastia: an evidence-based review». Expert Opinion on Drug Safety. 11 (5): 779–795. doi:10.1517/14740338.2012.712109. PMID 22862307.
Chau, A; Jafarian, N; Rosa, M (February 2016). «Male Breast: Clinical and Imaging Evaluations of Benign and Malignant Entities with Histologic Correlation». The American Journal of Medicine (Review). 129 (8): 776–91. doi:10.1016/j.amjmed.2016.01.009. PMID 26844632.
Devalia HL, Layer GT (April 2009). «Current concepts in gynaecomastia». Surgeon. 7 (2): 114–19. doi:10.1016/s1479-666x(09)80026-7. PMID 19408804.
Cordova A, Moschella F (2008). «Algorithm for clinical evaluation and surgical treatment of gynaecomastia». J Plast Reconstr Aesthet Surg. 61 (1): 41–9. doi:10.1016/j.bjps.2007.09.033. PMID 17983883.
Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B (2014 թ․ մարտի 19). «Gynecomastia: Clinical evaluation and management». Indian J Endocrinol Metab. 18 (2): 150–58. doi:10.4103/2230-8210.129104. PMC 3987263. PMID 24741509.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Dickson, G (April 2012). «Gynecomastia». American Family Physician. 85 (7): 716–722. PMID 22534349.
Deepinder, Fnu; Braunstein, Glenn D (2012). «Drug-induced gynecomastia: an evidence-based review». Expert Opinion on Drug Safety. 11 (5): 779–795. doi:10.1517/14740338.2012.712109. ISSN 1474-0338. PMID 22862307.
Barros, Alfredo Carlos Simões Dornellas de; Sampaio, Marcelo de Castro Moura (2012). «Gynecomastia: physiopathology, evaluation and treatment». São Paulo Medical Journal. 130 (3): 187–197. doi:10.1590/S1516-31802012000300009. ISSN 1516-3180. PMID 22790552. «Reinforcing the evidence suggesting that there is a relationship between chemicals and GM, it is worthwhile mentioning the epidemic onset observed among Haitian refugees in 1981 about four months after arrival in United States detention centers.22 After analyzing all identifiable environmental exposures, it was then found that phenothrin, a multi-insecticide contained in sprays that they had used was the causative agent.23 It is now widely known that phenothrin has antiandrogenic activity.»
Steven A. Brody MD; D. Lynn Loriaux MD (2003). «Epidemic Of Gynecomastia Among Haitian Refugees: Exposure To An Environmental Antiandrogen». Endocrine Practice. 9 (5): 370–375. doi:10.4158/EP.9.5.370. ISSN 1530-891X. PMID 14583418.
Grunseich, C; Fischbeck, KH (November 2015). «Spinal and Bulbar Muscular Atrophy». Neurologic Clinics. 33 (4): 847–54. doi:10.1016/j.ncl.2015.07.002. PMC 4628725. PMID 26515625.
Fukami, M; Miyado, M; Nagasaki, K; Shozu, M; Ogata, T (March 2014). «Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia». Pediatric Endocrinology Reviews. 11 (3): 298–305. PMID 24716396.
Farida, Chentli; Faiza, Belhimer (2013). «Severe gynecomastia due to anti androgens intake: A case report and literature review». Indian Journal of Endocrinology and Metabolism. 17 (4): 730–2. doi:10.4103/2230-8210.113770. ISSN 2230-8210. PMC 3743379. PMID 23961495.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Gillatt, David (2006). «Antiandrogen treatments in locally advanced prostate cancer: are they all the same?». Journal of Cancer Research and Clinical Oncology. 132 (S1): 17–26. doi:10.1007/s00432-006-0133-5. ISSN 0171-5216. PMID 16845534. «Unlike CPA, nonsteroidal antiandrogens appear to be better tolerated than castration, allowing patients to maintain sexual activity, physical ability, and bone mineral density, but these agents have a higher incidence of gynecomastia and breast pain (mild to moderate in > 90% of cases).»
Goldspiel BR, Kohler DR (1990). «Flutamide: An Antiandrogen for Advanced Prostate Cancer». Ann Pharmacother. 24 (6): 616–623. doi:10.1177/106002809002400612. PMID 2193461. «[...] They [in patients treated with flutamide] observed mild gynecomastia in 30 patients (57%), moderate gynecomastia in 19 (36%), and massive gynecomastia in four patients (8%). Complaints of nipple and areolar tenderness were noted in 50/53 patients (94%%)." Airhart et al. reported that 42% of patients receiving flutamide 750 mg/d or 1500 mg/d developed gynecomastia within 12 weeks of starting treatment with an apparent direct correlation between the dose of flutamide administered and the severity of gynecomastia. In another study, two of five evaluable patients developed moderate gynecomastia with mild tenderness at four and eight weeks after starting flutamide 750 mg/d. Patients with pre-existing gynecomastia as a result of previous endocrine therapy with estrogens sustained no worsening of their gynecomastia and may have improved symptomatically." Keating et al.»
Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF (April 2014). «Aldosterone antagonists for preventing the progression of chronic kidney disease». Cochrane Database of Systematic Reviews. 4 (4): CD007004. doi:10.1002/14651858.CD007004.pub3. PMID 24782282.
Aiman, U; Haseen, MA; Rahman, SZ (December 2009). «Gynecomastia: An ADR due to drug interaction». Indian Journal of Pharmacology. 41 (6): 286–287. doi:10.4103/0253-7613.59929. PMC 2846505. PMID 20407562.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Nieschlag, E; Vorona, E (August 2015). «MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions». European Journal of Endocrinology. 173 (2): R47–58. doi:10.1530/EJE-15-0080. PMID 25805894. Արխիվացված է օրիգինալից 2015 թ․ դեկտեմբերի 15-ին. Վերցված է 2020 թ․ հունվարի 11-ին.
Barros AC, Sampaio Mde C (2012). «Gynecomastia: physiopathology, evaluation and treatment». São Paulo Medical Journal. 130 (3): 187–97. doi:10.1590/s1516-31802012000300009. PMID 22790552.
Diaz A, Luque L, Badar Z, Kornic S, Danon M (2016). «Prepubertal gynecomastia and chronic lavender exposure: report of three cases». J. Pediatr. Endocrinol. Metab. 29 (1): 103–107. doi:10.1515/jpem-2015-0248. PMID 26353172.
Iglesias, P; Carrero, JJ; Diez, JJ (January–February 2012). «Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options». Journal of Nephrology. 25 (1): 31–42. doi:10.5301/JN.2011.8481. PMID 21748720. Արխիվացված է օրիգինալից 2014 թ․ ապրիլի 19-ին. Վերցված է 2013 թ․ փետրվարի 9-ին.
Gourgari, E; Saloustros, E; Stratakis, CA (August 2012). «Large-cell calcifying Sertoli cell tumors of the testes in pediatrics». Current Opinion in Pediatrics. 24 (4): 518–522. doi:10.1097/MOP.0b013e328355a279. PMC 4132931. PMID 22732638.
Saylor, PJ; Smith, MR (May 2009). «Metabolic complications of androgen deprivation therapy for prostate cancer». The Journal of Urology. 181 (5): 1998–2006. doi:10.1016/j.juro.2009.01.047. PMC 2900631. PMID 19286225.
Gies I, Unuane D, Velkeniers B, De Schepper J (August 2014). «Management of Klinefelter syndrome during transition». European Journal of Endocrinology. 171 (2): R67–77. doi:10.1530/EJE-14-0213. PMID 24801585. Արխիվացված է օրիգինալից 2015 թ․ նոյեմբերի 16-ին.
Koshy, JC; Goldberg, JS; Wolfswinkel, EM; Ge, Y; Heller, L (January 2011). «Breast cancer incidence in adolescent males undergoing subcutaneous mastectomy for gynecomastia: is pathologic examination justified? A retrospective and literature review». Plastic and Reconstructive Surgery. 127 (1): 1–7. doi:10.1097/PRS.0b013e3181f9581c. PMID 20871489.
Wollina, U; Goldman, A (June 2011). «Minimally invasive esthetic procedures of the male breast». Journal of Cosmetic Dermatology. 10 (2): 150–155. doi:10.1111/j.1473-2165.2011.00548.x. PMID 21649820.
Viani, GA; Bernardes da Silva, LG; Stefano, EJ (July 2012). «Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?». International Journal of Radiation Oncology, Biology, Physics. 83 (4): e519–e524. doi:10.1016/j.ijrobp.2012.01.036. PMID 22704706.
Wassersug, RJ; Oliffe, JL (April 2009). «The social context for psychological distress from iatrogenic gynecomastia with suggestions for its management». Journal of Sexual Medicine. 6 (4): 989–1000. doi:10.1111/j.1743-6109.2008.01053.x. PMID 19175864.
Wassersug, Richard J.; Oliffe, John L. (2009 թ․ ապրիլի 1). «The Social Context for Psychological Distress from Iatrogenic Gynecomastia with Suggestions for Its Management» (PDF). Journal of Sexual Medicine. 6 (4): 989–1000. doi:10.1111/j.1743-6109.2008.01053.x. PMID 19175864. Արխիվացված է օրիգինալից (PDF) 2018 թ․ սեպտեմբերի 9-ին. Վերցված է 2020 թ․ հունվարի 11-ին.

ncbi.nlm.nih.gov

Niewoehner, CB; Schorer, AE (March 2008). «Gynaecomastia and breast cancer in men». BMJ. 336 (7646): 709–713. doi:10.1136/bmj.39511.493391.BE. PMC 2276281. PMID 18369226.
Johnson RE, Murad MH (November 2009). «Gynecomastia: pathophysiology, evaluation, and management». Mayo Clinic Proceedings. 84 (11): 1010–1015. doi:10.4065/84.11.1010. PMC 2770912. PMID 19880691.
Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B (2014 թ․ մարտի 19). «Gynecomastia: Clinical evaluation and management». Indian J Endocrinol Metab. 18 (2): 150–58. doi:10.4103/2230-8210.129104. PMC 3987263. PMID 24741509.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Grunseich, C; Fischbeck, KH (November 2015). «Spinal and Bulbar Muscular Atrophy». Neurologic Clinics. 33 (4): 847–54. doi:10.1016/j.ncl.2015.07.002. PMC 4628725. PMID 26515625.
Farida, Chentli; Faiza, Belhimer (2013). «Severe gynecomastia due to anti androgens intake: A case report and literature review». Indian Journal of Endocrinology and Metabolism. 17 (4): 730–2. doi:10.4103/2230-8210.113770. ISSN 2230-8210. PMC 3743379. PMID 23961495.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Aiman, U; Haseen, MA; Rahman, SZ (December 2009). «Gynecomastia: An ADR due to drug interaction». Indian Journal of Pharmacology. 41 (6): 286–287. doi:10.4103/0253-7613.59929. PMC 2846505. PMID 20407562.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Gourgari, E; Saloustros, E; Stratakis, CA (August 2012). «Large-cell calcifying Sertoli cell tumors of the testes in pediatrics». Current Opinion in Pediatrics. 24 (4): 518–522. doi:10.1097/MOP.0b013e328355a279. PMC 4132931. PMID 22732638.
Saylor, PJ; Smith, MR (May 2009). «Metabolic complications of androgen deprivation therapy for prostate cancer». The Journal of Urology. 181 (5): 1998–2006. doi:10.1016/j.juro.2009.01.047. PMC 2900631. PMID 19286225.

nlm.nih.gov

«Breast enlargement in males». Medline Plus. US National Library of Medicine. Վերցված է 2015 թ․ նոյեմբերի 15-ին.

redjournal.org

Viani, GA; Bernardes da Silva, LG; Stefano, EJ (July 2012). «Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?». International Journal of Radiation Oncology, Biology, Physics. 83 (4): e519–e524. doi:10.1016/j.ijrobp.2012.01.036. PMID 22704706.

touro.edu

touroscholar.touro.edu

Narula HS, Carlson HE (August 2014). «Gynaecomastia-pathophysiology, diagnosis and treatment». Nat Rev Endocrinol. 10 (11): 684–698. doi:10.1038/nrendo.2014.139. PMID 25112235.

unitedhealthcareonline.com

«Coverage Determination Guideline Gynecomastia Treatment» (PDF). United HealthCare Services, Inc. 2012. Արխիվացված է օրիգինալից (PDF) 2014 թ․ ապրիլի 19-ին. Վերցված է 2019 թ․ մայիսի 6-ին.

web.archive.org

Nieschlag, E; Vorona, E (August 2015). «MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions». European Journal of Endocrinology. 173 (2): R47–58. doi:10.1530/EJE-15-0080. PMID 25805894. Արխիվացված է օրիգինալից 2015 թ․ դեկտեմբերի 15-ին. Վերցված է 2020 թ․ հունվարի 11-ին.
Iglesias, P; Carrero, JJ; Diez, JJ (January–February 2012). «Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options». Journal of Nephrology. 25 (1): 31–42. doi:10.5301/JN.2011.8481. PMID 21748720. Արխիվացված է օրիգինալից 2014 թ․ ապրիլի 19-ին. Վերցված է 2013 թ․ փետրվարի 9-ին.
Gies I, Unuane D, Velkeniers B, De Schepper J (August 2014). «Management of Klinefelter syndrome during transition». European Journal of Endocrinology. 171 (2): R67–77. doi:10.1530/EJE-14-0213. PMID 24801585. Արխիվացված է օրիգինալից 2015 թ․ նոյեմբերի 16-ին.
«Coverage Determination Guideline Gynecomastia Treatment» (PDF). United HealthCare Services, Inc. 2012. Արխիվացված է օրիգինալից (PDF) 2014 թ․ ապրիլի 19-ին. Վերցված է 2019 թ․ մայիսի 6-ին.
«Cigna Medical Coverage Policy» (PDF). Surgical Treatment of Gynecomastia. Cigna. 2012. Արխիվացված է օրիգինալից (PDF) 2012 թ․ սեպտեմբերի 5-ին. Վերցված է 2013 թ․ փետրվարի 12-ին.
Wassersug, Richard J.; Oliffe, John L. (2009 թ․ ապրիլի 1). «The Social Context for Psychological Distress from Iatrogenic Gynecomastia with Suggestions for Its Management» (PDF). Journal of Sexual Medicine. 6 (4): 989–1000. doi:10.1111/j.1743-6109.2008.01053.x. PMID 19175864. Արխիվացված է օրիգինալից (PDF) 2018 թ․ սեպտեմբերի 9-ին. Վերցված է 2020 թ․ հունվարի 11-ին.

worldcat.org

Deepinder, Fnu; Braunstein, Glenn D (2012). «Drug-induced gynecomastia: an evidence-based review». Expert Opinion on Drug Safety. 11 (5): 779–795. doi:10.1517/14740338.2012.712109. ISSN 1474-0338. PMID 22862307.
Barros, Alfredo Carlos Simões Dornellas de; Sampaio, Marcelo de Castro Moura (2012). «Gynecomastia: physiopathology, evaluation and treatment». São Paulo Medical Journal. 130 (3): 187–197. doi:10.1590/S1516-31802012000300009. ISSN 1516-3180. PMID 22790552. «Reinforcing the evidence suggesting that there is a relationship between chemicals and GM, it is worthwhile mentioning the epidemic onset observed among Haitian refugees in 1981 about four months after arrival in United States detention centers.22 After analyzing all identifiable environmental exposures, it was then found that phenothrin, a multi-insecticide contained in sprays that they had used was the causative agent.23 It is now widely known that phenothrin has antiandrogenic activity.»
Steven A. Brody MD; D. Lynn Loriaux MD (2003). «Epidemic Of Gynecomastia Among Haitian Refugees: Exposure To An Environmental Antiandrogen». Endocrine Practice. 9 (5): 370–375. doi:10.4158/EP.9.5.370. ISSN 1530-891X. PMID 14583418.
Farida, Chentli; Faiza, Belhimer (2013). «Severe gynecomastia due to anti androgens intake: A case report and literature review». Indian Journal of Endocrinology and Metabolism. 17 (4): 730–2. doi:10.4103/2230-8210.113770. ISSN 2230-8210. PMC 3743379. PMID 23961495.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Gillatt, David (2006). «Antiandrogen treatments in locally advanced prostate cancer: are they all the same?». Journal of Cancer Research and Clinical Oncology. 132 (S1): 17–26. doi:10.1007/s00432-006-0133-5. ISSN 0171-5216. PMID 16845534. «Unlike CPA, nonsteroidal antiandrogens appear to be better tolerated than castration, allowing patients to maintain sexual activity, physical ability, and bone mineral density, but these agents have a higher incidence of gynecomastia and breast pain (mild to moderate in > 90% of cases).»

yimg.com

xa.yimg.com

Wassersug, Richard J.; Oliffe, John L. (2009 թ․ ապրիլի 1). «The Social Context for Psychological Distress from Iatrogenic Gynecomastia with Suggestions for Its Management» (PDF). Journal of Sexual Medicine. 6 (4): 989–1000. doi:10.1111/j.1743-6109.2008.01053.x. PMID 19175864. Արխիվացված է օրիգինալից (PDF) 2018 թ․ սեպտեմբերի 9-ին. Վերցված է 2020 թ․ հունվարի 11-ին.